● Recruiting

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

Condition: Non-obstructive Hypertrophic Cardiomyopathy · Sponsor: Imbria Pharmaceuticals, Inc.

PhasePhase 2

Planned participants165

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxstat compared to placebo on top of Standard of Care in patients with symptomatic nHCM

This description comes directly from the study's public registry record.

Talk to the study team

Medical Monitor · (617) 675-4060 · info@imbria.com

Always discuss trial participation with your own doctor first.

Locations (67)

Imbria Investigational Site	La Jolla, California, United States	Recruiting
Imbria Investigational Site	Los Angeles, California, United States	Recruiting
Imbria Investigational Site	San Francisco, California, United States	Recruiting
Imbria Investigational Site	Washington D.C., District of Columbia, United States	Recruiting
Imbria Investigational Site	Miami, Florida, United States	Recruiting
Imbria Investigational Site	Chicago, Illinois, United States	Recruiting
Imbria Investigational Site	Oak Lawn, Illinois, United States	Not Yet Recruiting
Imbria Investigational Site	Baltimore, Maryland, United States	Recruiting
Imbria Investigational Site	Boston, Massachusetts, United States	Recruiting
Imbria Investigational Site	Burlington, Massachusetts, United States	Recruiting
Imbria Investigational Site	Grand Rapids, Michigan, United States	Recruiting
Imbria Investigational Site	Rochester, Minnesota, United States	Recruiting

+ 55 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07023614